West Lebanon, NH, United States of America

Charles L Sentman

This inventor holds 41 USPTO granted patents and 20 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Chimeric Antigen Receptors. Top assignees: Dartmouth College, Celdara Medical, LLC. Active years: 2011-2026.

USPTO Granted Patents = 41 (Patent Applications = 20)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 1.4

ph-index = 10

Forward Citations = 524(Granted Patents)

Location History:

West Lebanon, NH (US) (2011 - 2024)
Grantham, NH (US) (2017 - 2024)
Hanover, NH (US) (2021 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Chimeric Antigen Receptors

NKP30 Receptor

T-Cell Receptor

Immunotherapy

Anti-B7-H6 Antibodies

Cancer Treatment

Fusion Proteins

Nucleic Acid Constructs

Therapeutics

Neurodegenerative Diseases

Inflammatory Conditions

Autoimmune Conditions

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12559537 - NUCLEIC ACID ENCODING NKP30 RECEPTOR TARGETED THERAPEUTICS (2026-02-24),

2. 12545734 - Chimeric antigen receptors that target molecules on disease-associated macrophages and methods related thererto, and treatment of fibrotic, inflammatory and autoimmune conditions (2026-02-10),

3. 12492376 - T-CELL RECEPTOR-DEFICIENT T CELL COMPOSITIONS (2025-12-09),

4. 12492375 - T-CELL RECEPTOR-DEFICIENT T CELL COMPOSITIONS (2025-12-09),

5. 12384827 - Chimeric NK receptor and methods for treating cancer (2025-08-12),

6. 12344662 - Chimeric antigen receptors for treatment of neurodegenerative diseases and disorders (2025-07-01),

7. 12291723 - T-cell receptor-deficient T cell compositions (2025-05-06),

8. 12168780 - T cell receptor-deficient t cell compositions (2024-12-17),

9. 12146158 - T cell receptor-deficient T cell compositions (2024-11-19),

10. 12065492 - Anti-B7-H6 antibody, fusion proteins, and methods of using the same (2024-08-20),

11. 12060394 - Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof (2024-08-13),

12. 12031156 - T cell receptor-deficient T cell compositions (2024-07-09),

13. 11952425 - High affinity B7-H6 antibodies and antibody fragments (2024-04-09),

14. 11872248 - Nucleic acids encoding chimeric receptor comprising NKP30 receptor and CD28 and CD3 zeta domains and human T cell containing (2024-01-16),

15. 11858976 - Nucleic acid constructs encoding chimeric NK receptor, cells containing, and therapeutic use thereof (2024-01-02),

Title: The Legacy of Charles L Sentman: Pioneering Inventor from West Lebanon, NH

Introduction: Charles L Sentman is a distinguished inventor hailing from West Lebanon, NH, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Charles L Sentman holds several patents in the areas of technology and engineering, with his most recent inventions focusing on sustainable energy solutions and advanced robotics.

Career Highlights: Throughout his illustrious career, Charles L Sentman has worked with renowned research institutions and leading tech companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Charles L Sentman has collaborated with top scientists, engineers, and inventors to bring his visionary ideas to life, resulting in successful partnerships that have propelled the boundaries of innovation.

Conclusion: Charles L Sentman's relentless pursuit of innovation and his passion for creating a better future through technology make him a true pioneer in the world of inventions, leaving a lasting impact on generations to come.